Loading...

AKRO - Akero Therapeutics, Inc.

Top Biomed Signal for 05-07-2022
Top Biomed Stock Signal: AKRO


Loading Chart AKRO

Stock Signal Information


Signal

Top Biomed Stock Signal: AKRO
Report Date: 05-07-2022
Symbol: AKRO - Akero Therapeutics, Inc.
Sector:
Industry:
Top Biomed Stock Signal: AKRO

  AKRO Technical Analysis

Company Contact

Akero Therapeutics, Inc. (AKRO)
170 Harbor Way
South San Francisco, CALIFORNIA 94080
Phone: 16504876488
Website: http://www.akerotx.com
CEO: Dr. Andrew Cheng

AKRO, Akero Therapeutics, Inc.

AKRO Akero Therapeutics, Inc. Logo Image

NASDAQ, Nasdaq Global Select


Company Profile

Akero Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for serious metabolic diseases. Its lead product candidate is AKR-001, which is in Phase IIa clinical trial for the treatment of nonalcoholic steatohepatitis disease.The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was founded in 2017 and is headquartered in South San Francisco, California.